Change in MAPSE During Treatment of Sepsis
Evaluation of Mitral Annulus Systolic Plane Excursion (MAPSE) in Emergency Department Patients With Sepsis
1 other identifier
observational
50
1 country
1
Brief Summary
Patients with bloodstream infections (sepsis) have been found in prior studies to have infection-related heart dysfunction, even if they did not have preexisting heart problems. Factors related to the infection may cause the heart to not pump as well as it should, causing critical illness in the form of low blood pressure (shock) and heart failure. Ultrasound is frequently used in the emergency department to evaluate why a patient might have low blood pressure. Part of that evaluation may include obtaining ultrasound images and making measurements about how well or poorly the heart is pumping. The investigators will evaluate a certain measurement that relates to cardiac function, determine how it changes in patients before and after they are treated for septic shock. This will involve placing an ultrasound probe on the patient's chest, measuring the upward and downward movement of the mitral valve, the mitral annulus systolic plane excursion (MAPSE), and comparing the measurements before and after treatment is started. The investigators are attempting to determine if this measurement improves before and after treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 22, 2022
CompletedFirst Posted
Study publicly available on registry
December 2, 2022
CompletedStudy Start
First participant enrolled
April 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2030
June 19, 2025
June 1, 2025
7 years
November 22, 2022
June 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in MAPSE measurement
Does the MAPSE change after treatment of MAPSE
1 hour after treatment initiation
Study Arms (1)
Patients with Sepsis
These are patients who present to the emergency department with sepsis. They will have a MAPSE at the time of enrollment and then after initial treatment.
Interventions
Eligibility Criteria
adult emergency department patients who present with sepsis
You may qualify if:
- Diagnosis of Sepsis or Septic Shock
You may not qualify if:
- Age equal to or less than 17
- patient in the emergency department
- Unable to perform POCUS exam due to medical necessity
- Patients without sepsis
- unable to obtain consent or have a legal representative consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Maryland Medical Center
Baltimore, Maryland, 21201, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Emergency Medicine
Study Record Dates
First Submitted
November 22, 2022
First Posted
December 2, 2022
Study Start
April 1, 2023
Primary Completion (Estimated)
April 1, 2030
Study Completion (Estimated)
December 1, 2030
Last Updated
June 19, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share